March 15, 2020 –  An international study published in the journal Cell has described 109 genetic variants associated with eight psychiatric disorders such as autism, ADHD, schizophrenia, bipolar disorder, depression, obsessive-compulsive disorder and Tourette syndrome in a total of about 230,000 …

Large genetic map of psychiatric disorders completed Read more »

Tagged with: , , , , , , , , , , , , , ,

November 16, 2017 – The American Food & Drug Administration (FDA) just approved Ability MyCite,  a pill with a sensor that digitally tracks if patients have ingested their medication. This is a very first in its class at the new age …

Abilify MyCite, the first digital pill. Where does all that silicone go? Read more »

Tagged with: , , , , , , , , , ,

May 11, 2016 – We do learn from a very recent Drug Safety Communication (DSC) by the American Food & Drug Administration (FDA) that olanzapine, the pharmacologically active component in Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, Symbyax, and olanzapine generics may cause …

DRESS: Rare but serious skin reaction with Zyprexa (Olanzapine) Read more »

Tagged with: , , , , , , , , ,

 September 19, 2015 – The American Food and Drug Administration (FDA) just approved Cariprazine (Vraylar) capsules to treat schizophrenia and bipolar disorder in adults. Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, …

Cariprazine (Vraylar): New treatment for schizophrenia and bipolar disorder approved Read more »

Tagged with: , , , , ,

July 19, 2015 – Very recently, the U.S. Food and Drug Administration (FDA) approved Brexpiprazole (Rexulti) tablets to treat adults with schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD). Schizophrenia …

Brexpiprazole (Rexulti): A new drug to treat schizophrenia and as an add on to an antidepressant to treat major depressive disorder approved by the FDA Read more »

Tagged with: , , ,

September 01, 2011 – Asenapine Maleate [Saphris] is used to treat symptoms of schizophrenia and bipolar disorder. The American Food and Drug Administration (FDA) has notified healthcare professionals and patients that serious allergic reactions have been reported with the use …

Drug Safety Communication: Asenapine Maleate [Saphris] Associated with Serious Allergic Reactions Read more »

Tagged with: , , ,